Skip to main content

Table 1 Clinicopathological data of the included patients

From: St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial

Characteristics Number of patients (%)
All patients   85 (100)
Age Median (range) 64 (26–76)
HER2 Positive 17 (20)
  Negative 68 (80)
Ki67 ≤ 20% 54 (74)
  > 20% 19 (26)
ER status Positive 62 (73)
  Negative 23 (27)
Pr status Positive 41 (48)
  Negative 44 (52)
Histology Ductal 67 (81)
  Lobular 10 (12)
  Ductal + Lobular 4 (5)
  Other 2 (2)
  Missing 2
Tumor size ≤ 20% 25 (29)
  > 20% 60 (71)
Grade 1 2 (3)
  2 36 (60)
  3 22 (37)
  Missing 25
Nodal status N1 22 (26)
  N2-3 25 (29)
  N4+ 38 (45)
Events1 Yes 25 (29)
  No 60 (71)
  1. Abbreviations: ER oestrogen receptor, PR progesteron receptor, HER2 human epidermal growth factor receptor 2, Grade Nottingham histological grade.
  2. 1Events: recurrence and/or death in breast cancer disease.